Skip to main content

UM School Of Medicine Institute of Human Virology’s Robert Gallo Receives Distinguished Alumni Award by the University of Chicago Medical Association

April 05, 2022 | Nora Samaranayake


Robert Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine and co-founder and Chair of the Scientific Leadership Board of the Global Virus Network, was awarded the Distinguished Alumni Award by the University of Chicago Medical & Biological Sciences Alumni Association (UChicago MBSAA) for his lifetime achievements. Honorees will participate in a panel discussion on May 10 and will be presented the award on May 21 at the Hyde Parke campus.

“Being at the University of Chicago was a great inspiration for me by being so surrounded by excellence and by mentors who delighted in helping the beginning physician-scientist,” said Robert C. Gallo, MD, ’65. “I will never forget those days which deeply impacted my entire career. Obviously, I am honored and grateful to receive this recognition.”

“The University of Chicago uniquely nurtured scientific discovery in Dr. Gallo's training in the practice of medicine,” said I. David Goldman, MD, ’62, Susan Fischer Chair, Albert Einstein College of Medicine and Director Emeritus, Albert Einstein Cancer Center. “This was followed by the National Cancer Institute's recognition of the extraordinary talent and passion of a young physician-scientist providing Dr. Gallo with the freedom and resources to go on to make seminal discoveries on the biology of retroviruses and human T-cells that culminated in unraveling the causation of human T-cell leukemia and AIDS.” Dr. Goldman is a former resident of the University of Chicago.

“The UChicago MBSAA takes great pride in recognizing our alumni who, through their work, have made significant contributions to the biological sciences and medicine,” said Mark R. Aschliman, MD, '80, Chair, Alumni Awards Committee.

Dean E. Albert Reece, MD, PhD, MBA, Executive Vice President for Medical Affairs, University of Maryland Baltimore, and the John Z. and Akiko K. Bowers Distinguished Professor at the University of Maryland School of Medicine, said, “My sincerest congratulations to Dr. Robert Gallo for receiving this prestigious award from one of our most preeminent academic medical institutions. Dr. Gallo is a world-renowned scientist whose breakthrough discoveries and scholarly contributions have made major contributions to global health for more than four decades. He is a visionary investigator who has unlocked many important mysteries of human viruses and diseases. He embodies all of the attributes of what it means to be a great scientist. We have been fortunate to have him as one of our most distinguished members of the University of Maryland School of Medicine faculty for many years. He has led our Institute of Human Virology, which has been transformative in its work to eradicate chronic and deadly viral and immune disorders. He is most deserving of this honor from the University of Chicago Medical Alumni Association.”

Dr. Gallo graduated from Thomas Jefferson University School of Medicine before completing his medical training at the University of Chicago. After 30 years at the National Cancer Institute at the National Institutes of Health in Bethesda, Maryland, he became the co-founder of the Institute of Human Virology and the founding director and The Homer & Martha Gudelsky Distinguished Professor of Medicine and Microbiology and Immunology at the University of Maryland School of Medicine. In 2011, Dr. Gallo became the Co-Founder and Chair of the Scientific Leadership Board to the Global Virus Network.

Dr. Gallo’s career interests have focused on studying the basic biology of human blood cells, their normal and abnormal growth, and the involvement of viruses in these abnormalities.

Dr. Gallo and his co-workers pioneered human retrovirology, discovering the first human retrovirus (HTLV-1) and, along with others, showing it was a cause of a particular form of human leukemia. A year later, he and his group discovered the second known human retrovirus (HTLV-2). Dr. Gallo and his colleagues independently discovered HIV and provided the first results to show it was the cause of AIDS. They also developed a lifesaving HIV blood test. In 1986, he and his co-workers discovered the first new human herpes in more than 25 years, Human Herpes Virus-6 (HHV-6). Previously in 1978, Gallo discovered a variant of gibbon ape leukemia virus—Hall’s Island strain—which causes T-cell leukemia.

Dr. Gallo and his co-workers discovered Interleukin-2 in 1976, thus setting the stage for all groups to culture human T-cells. Gallo and his co-workers spent years developing detailed biochemical and immunological characteristics of human cellular DNA polymerases alpha, beta, and gamma and reverse transcriptase (RT) from several retroviruses to use RT as a sensitive and specific surrogate marker for retroviruses.

In 1995 he and his colleagues discovered the first natural (endogenous) inhibitors of HIV, which led to the discovery of the HIV co-receptor, CCR5, and opened new approaches to treatment. Currently, Dr. Gallo and his team have been working on a HIV preventive vaccine candidate.

Dr. Gallo has received 35 honorary doctorates from universities around the world. He was the most cited scientist from 1980 to 1990 and was ranked third in the world for scientific impact from 1983 to 2002, publishing nearly 1,300 papers.

Dr. Gallo is a member of the National Academy of Sciences and the National Academy of Medicine and has received several international prizes, including the U.S. Albert Lasker Award twice.

About the Institute of Human Virology

Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland, and the University of Maryland Medical System, the IHV is an institute of the University of Maryland School of Medicine and is home to some of the most globally-recognized and world-renowned experts in all of virology. The IHV combines the disciplines of basic research, epidemiology, and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably, HIV the virus that causes AIDS. For more information, visit www.ihv.org and follow us on Twitter @IHVmaryland.

Contact

Institute of Human Virology
Nora Samaranayake
Chief Communications & Public Affairs Officer
(443) 823-0613 (phone)
(410) 706-1952 (fax)
nsamaranayake@ihv.umaryland.edu

Related stories

    Tuesday, August 09, 2022

    CNBC: ‘We don’t even agree on how to define it yet’: It’s year three of the pandemic and scientists still know very little about long COVID

    We’ve entered year three of the pandemic, and experts still know very little about long Covid, including how to cure its symptoms. On July 20th and July 21st, the Global Virus Network hosted the first-ever conference devoted solely to the science of long COVID. There, scientists spoke openly about what is known about the mysterious condition and the questions that remain.


    Monday, July 25, 2022

    Institute of Human Virology at the University of Maryland School of Medicine Supports First-of-Its-Kind Conference to Evaluate the Public Health Magnitude of Long COVID And Define A Global Research Roadmap to Address the Crisis

    The conference, hosted at the University of Maryland, Baltimore, reviewed the wealth of cohort data on long COVID, constructed a framework to characterize and define the conditions, and identified the most critical and urgent areas of research needed to better understand, diagnose, and treat this developing public health crisis.


    Friday, July 22, 2022

    STAT: ‘There’s no one long COVID’: Experts struggle to make sense of the continuing mystery

    Presented by the Global Virus Network, a coalition of leading virologists, the two-day virtual conference convened at the University of Maryland, Baltimore where experts across disciplines and around the world to ask and answer questions about what causes long COVID, how to predict who gets it, how to treat it, and just possibly how to prevent it.


    Tuesday, May 24, 2022

    Baltimore Sun: Monkeypox ‘isn’t COVID,’ but CDC still wants public to be aware of cases

    Officials from the U.S. Centers for Disease Control and Prevention warned the public and medical providers Monday to be on alert for possible cases of monkeypox as it counts up to five cases of the normally rare disease around the nation. But the officials say the threat to the general public remains low, as it’s just not as easily spread as other diseases such as COVID-19. Rather, it takes touching or sharing fluids with someone with the characteristic monkeypox rash.


    Thursday, May 19, 2022

    Baltimore Sun: With COVID cases rising, you’re still not fully vaxxed or boosted? Come on now.

    Dan Rodricks: I recently had conversations with a middle-aged man who is extremely careful about what he puts into his body. He eats lots of fruits and vegetables and stays away from red meat and processed foods. He also refuses to get the vaccine against COVID-19, even as infections are on the rise again.


    Friday, March 18, 2022

    Deutsche Presse-Agentur: Virus hunt for decades: US researcher Robert Gallo turns 85

    Few scientists in the world can come up with as many successes as Robert Gallo: The US researcher was involved in the discovery of the AIDS virus, found leukemia pathogens and other deadly viruses. Now he is 85 - and works even harder than before.


    Wednesday, February 23, 2022

    TIME: Knowing the Origins of COVID-19 Won't Change Much

    Over two years since the first cases started appearing in Wuhan, China, there is much we don’t know about the origins of SARS-CoV-2, the virus causing COVID-19. But a quick resolution to that question is possible: scientists could find bats in a cave somewhere in China or in southeast Asia and trace a chain leading from those bats to the COVID-19 outbreak in Wuhan. Realistically, however, recent history offers little promise for this to happen quickly.


    Wednesday, February 16, 2022

    WBAL: Maryland HIV researcher on latest research: It's not a cure

    Scientists used a cutting-edge stem cell transplant method to treat a woman's HIV, but a lead researcher in Maryland said it's too soon to celebrate. A U.S. woman is the third known person who is in HIV remission after receiving stem cells from umbilical cord blood, an American research team announced Wednesday.


    Tuesday, February 08, 2022

    The New Yorker: Beyond the Booster Shot

    Could a “broad spectrum” booster increase our immunity to many pathogens simultaneously? The first tuberculosis vaccine was developed in 1921, by two French scientists, Albert Calmette and Camille Guérin. It was called Bacillus Calmette-Guérin, or B.C.G., and has long been one of the world’s most widely administered shots. From the beginning, its power was surprising. B.C.G. contains a bacterium similar to the one that causes TB, and engenders an immune defense specific to that disease. But, as Calmette noted in a paper in 1931, those vaccinated with B.C.G. at birth were around seventy-five per cent less likely to die in their early years of any cause.


    Tuesday, January 04, 2022

    Economy.bg: What do scientists want for 2022?

    Economy.bg asked scientists from Bulgaria and the world what they hope for in 2022.


    Wednesday, December 22, 2021

    Economy.bg: The year through the eyes of scientists

    Economy.bg asked scientists in our country and around the world what they think is the most important of the past 2021


    Thursday, December 16, 2021

    Ren TV (Russia): Virologist who discovered HIV urged to vaccinate children

    Robert Gallo, director and co-founder of the Institute of Human Virology at the University of Maryland and co-founder of the Global Virus Network, discussed why it is important to vaccinate children against coronavirus.


    Tuesday, October 26, 2021

    Correio Braziliense: "It's obvious that no vaccine causes AIDS," says one of the virologists who discovered HIV

    The virologist, and one of the discoverers of HIV, speaks to Correio about statements by President Bolsonaro live on social media


    Friday, July 23, 2021

    WUSA: VERIFY: Here's a look at Japan's vaccination plan

    People online claim the Olympics are in jeopardy because the country has no plan to vaccinate its population. That's false.


    Thursday, July 08, 2021

    Bloomberg News: Dr. Gallo Says COVID-19 Is a Solvable Problem

    Dr. Robert Gallo, The Global Virus Network Co-founder and Director at University of Maryland says COVID-19 is a solvable problem, as obviously it was easy to get a solvable vaccine.


    Saturday, July 03, 2021

    India Today: Exclusive: Virologist Dr. Robert Gallo Speaks On Third Wave, Effects On Children & Other COVID Issues

    Will India and the world see a third wave, if yes then when? How much the third wave will affect children? If mRNA vaccine is the future of COVID-19 vaccines? World's top virologist, Dr. Robert Gallo, answers these and many other questions related to COVID-19 and its vaccination in an exclusive conversation with Rajdeep Sardesai.


    Friday, June 25, 2021

    Doctor Radio: What We Know About the Virology of COVID-19

    Dr. Marc Siegel talks to the Co-founder & Director of the Institute of Human Virology at the University of Maryland School of Medicine and Co-founder for the Global Virus Network, Dr. Robert Gallo, as well as the President of the Global Virus Network, Dr. Christian Brechot, about COVID-19 Origin, Immunity, Vaccines, and Variants.


    Friday, June 25, 2021

    Weather Channel: Mystery Thickens Over COVID-19's Origin; Claims of Hidden Early Genetic Information Attracts Further Scrutiny

    COVID-19 pandemic has been wreaking worldwide havoc for nearly 20 months now. Yet, Its origin and early spread continue to be one of the most intriguing scientific puzzles of recent history. Claims that the earliest coronavirus strains leaked out from a lab in the Wuhan Institute of Virology in China have resurfaced and subsided multiple times, throughout the course of the pandemic. While many such claims were eventually disregarded as unfounded speculations of conspiracy theorists, allegations have continued against the Wuhan lab having known about the infection and its subsequent threat, much before the world at large was aware.


    Tuesday, June 22, 2021

    The Washington Post: Wuhan lab’s classified work complicates search for pandemic’s origins

    The Wuhan lab has drawn global scrutiny because of its research on bat coronaviruses in the city where the pandemic began. The events have shined a light on a research niche that — in China, the United States and elsewhere — operates with heightened secrecy because of the national security risks of handling deadly pathogens.


    Monday, June 21, 2021

    Reuters: India should brace for third COVID-19 wave by Oct, say health experts

    A third wave of coronavirus infections is likely to hit India by October, and although it will be better controlled than the latest outbreak the pandemic will remain a public health threat for at least another year, according to a Reuters poll of medical experts.


    Thursday, June 17, 2021

    Big Biology Podcast: Old vaccines for new pandemics (Episode 66)

    What has COVID-19 taught us about preparing for future epidemics? Can we trigger innate immune responses – our first lines of defense - to mitigate novel infections? Can we use live-attenuated vaccines (LAV) meant for other infections to protect us while we develop specific vaccines for new pathogens? On this episode, we talk to virologists Konstantin Chumakov and Robert Gallo about their recent paper entitled “Old vaccines for new infections”.


    Thursday, June 03, 2021

    Slate: A Very Calm Guide to the Lab Leak Theory

    More than a year into the COVID-19 pandemic, scientists still aren’t sure where exactly the virus that caused this mess came from, and how it was able to spread so rapidly among humans. With the origins of the coronavirus still up in the air, there’s been a lot of talk of the so-called lab leak theory—the idea that the virus spread to people in a laboratory accident, rather than jumping from a wild animal to a human. In recent days, there’s been a flurry of speculation, and it can be hard to parse what the lab leak theory is all about, how likely it is, and why it matters at all. Here’s our attempt to sort some of that out.


    Tuesday, June 01, 2021

    SciDevNet: ‘Old vaccines can fight new pandemics like COVID-19’

    Inoculation with live attenuated vaccines (LAV) such as those used against TB, polio or measles can stimulate the immune system to provide protection against other infectious diseases, including COVID-19, says a new study. People who have been inoculated with one or more LAVs but have no access to the new, specific vaccines against COVID-19 — typically because they are expensive or in short supply — may have some protection during the current pandemic, according to the study.


    Thursday, May 27, 2021

    Baltimore Sun: Maryland researchers study whether HIV cure can come from infusing patients with genetically modified ‘super T cells’

    A week ago, a Washington, D.C., man in his 30s with HIV became the first person to be infused with a heaping load of his own genetically modified cells that a Maryland biotech firm believes one day could lead to the elusive cure for the disease. American Gene Technologies’ method involves taking T cells out of a person’s blood and genetically modifying them in the lab to resist infection before they are reinfused. C. David Pauza is the company’s chief science officer and a former professor and researcher at the University of Maryland School of Medicine’s Institute for Human Virology. Another center evaluating entering the study is Maryland’s Institute for Human Virology, confirmed its co-founder and director, Dr. Robert Gallo, who is internationally regarded for his role in discovering HIV and developing a blood test to detect it.


    Tuesday, May 18, 2021

    Institute of Human Virology Leadership Contributes to Global Virus Network Analysis Suggesting Measles, Polio and Tuberculosis Vaccines May Boost Immunity to Coronavirus

    Institute of Human Virology at the University of Maryland School of Maryland scientists, who are also members of the Global Virus Network (GVN), a coalition comprised of human and animal virologists from 63 Centers of Excellence and 11 Affiliates in 35 countries, and colleagues today published a perspective proposing that live attenuated vaccines (LAVs), such as those for tuberculosis, measles, and polio, may induce protective innate immunity that mitigate other infectious diseases, triggering the human body’s natural emergency response to infections including COVID-19 as well as future pandemic threats.


    Monday, April 19, 2021

    Bloomberg TV: Will Vaccines Protect Us From All Covid-19 Variants?

    Dr. Robert Gallo, co-founder of the Global Virus Network and director of the Institute of Human Virology at the University of Maryland School of Medicine, discusses the global rollout of Covid-19 vaccines. Global cases passed 141 million, and deaths exceeded 3 million. Gallo speaks with Haidi Stroud-Watts and Shery Ahn on "Bloomberg Daybreak: Australia."


    Monday, April 19, 2021

    China Business Network: An interview with Dr. Gallo on COVID-19, Variants and Vaccines

    In an exclusive interview with CBN, Dr. Robert Gallo, a world-renowned virus expert, speculated that certain components of Johnson & Johnson and AstraZeneca vaccines may induce the immune system to produce an antibody, which can cause a very small number of people. Heparin-induced thrombocytopenia, thrombosis.


    Friday, April 09, 2021

    Aljazeera: Which vaccine is best? The one you can get first, experts say

    As the United States ramps up its COVID-19 inoculation campaign, aiming to make vaccines available to all adults by April 19, some doctors and health workers are concerned that brand preferences among potential vaccine recipients could hurt attempts to slow the spread of the virus.


    Thursday, April 01, 2021

    Associated Press: Can I still spread the coronavirus after I’m vaccinated?

    Can I still spread the coronavirus after I’m vaccinated? It’s possible. Experts say the risk is low, but are still studying how well the shots blunt the spread of the virus. The current vaccines are highly effective at preventing people from getting seriously sick with COVID-19.


    Monday, December 21, 2020

    Robert Gallo of the UM School of Medicine Institute of Human Virology and Global Virus Network Awarded Top Life Sciences and Medicine Prize from China

    Robert C. Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine and co-founder and international scientific advisor of the Global Virus Network, was awarded the “VCANBIO Award for Biosciences and Medicine,” a significant and authoritative award in the life sciences and medicine field of China. The elite Prize is jointly presented by the University of Chinese Academy of Sciences and the VCANBIO CELL & GENE ENGINEERING CORP, LTD to push forward scientific research, technological innovation and continuous development in the life sciences and medicine field of China.


    Friday, December 18, 2020

    UMSOM Institute of Human Virology's Robert Gallo Awarded Italy's Magna Graecia International Prize

    Robert Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine and co-founder and international scientific advisor of the Global Virus Network, was awarded Italy’s “Magna Graecia International Prize,” an award created in 1997 by the Magna Graecia Foundation that is bestowed to the most influential Italians and Italians of origin who have embodied and symbolized, in the most diverse sectors, the best qualities of Italy by extending Italian culture beyond national borders.


    Thursday, October 08, 2020

    NPR: Could The Live Flu Vaccine Help You Fight Off COVID-19?

    In case you were still procrastinating getting a flu shot this year, here's another reason to make it a priority. There's a chance the vaccine could offer some protection against COVID-19 itself, says virologist Robert Gallo, who directs the Institute of Human Virology at the University of Maryland School of Medicine and is chairman of the Global Virus Network.


    Thursday, September 24, 2020

    Baltimore Sun: A vaccine will help, not end coronavirus pandemic, experts in Maryland and globally say

    A global group of virus experts warned Thursday about relying too much on the first vaccines to end the coronavirus pandemic. “If we get a perfect vaccine, great, but that’s unlikely,” said Dr. Robert Gallo, co-founder of the Global Virus Network, during a news conference following a meeting of the organization that works to understand and treat infectious diseases.


    Friday, August 21, 2020

    Institute of Human Virology and Italian Researchers identify a SARS-CoV-2 Viral Strain with Deletion in a Protein, Possibly Reducing Fatalities

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine, a Global Virus Network (GVN) Center of Excellence, in collaboration with scientists from Campus Biomedico in Rome, Italy announced today the results of studies showing the emergence of a SARS-CoV-2 viral strain with a deletion in a protein known as nsp1. These data, accepted for publication today by the Journal of Translational Medicine, (link here) may indicate the emergence of a less pathogenic viral strain.


    Tuesday, June 30, 2020

    Wall Street Journal Op-Ed: An Old Vaccine May Help Against Coronavirus: A tablet for polio boosts innate immunity, which fights other viruses.

    In this op-ed coauthored by Dr. Robert C. Gallo and Daniel J. Arbess, they discuss how “An Old Vaccine May Help Against Coronavirus: A tablet for polio boosts innate immunity, which fights other viruses.”


    Monday, June 29, 2020

    Baltimore Magazine Special Edition: Dr. Gallo Featured

    Dr. Robert Gallo is featured in Baltimore Magazine's special edition, "On the Front Lines: Acts of Courage and Kindness in the Age of Coronavirus."


    Thursday, June 11, 2020

    Global Virus Network Suggests Oral Polio Vaccine May Provide Temporary Protection Against COVID-19

    The Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 53 Centers of Excellence, including the Institute of Human Virology at the University of Maryland School of Medicine, and 10 Affiliates in 32 countries, published a viewpoint in Science today that the stimulation of innate immunity by live attenuated vaccines in general, and oral poliovirus vaccine (OPV) in particular, could provide temporary protection against coronavirus disease 2019 (COVID-19).


    Friday, May 01, 2020

    NYT Op-Ed Features Gallo-Chumakov Oral Polio Vaccine for COVID-19 Idea

    What if We Already Have a Coronavirus Vaccine? Researchers are testing whether decades-old vaccines for polio and tuberculosis could protect against infection.


    Wednesday, April 29, 2020

    Dr. Robert Gallo Appears on C-SPAN’s Washington Journal

    Please check out Dr. Robert Gallo’s C-SPAN Washington Journal appearance today to discuss COVID-19 treatments, vaccines, the need for the Global Virus Network, and more.


    Monday, April 27, 2020

    Expert Breaks Down Coronavirus Research: Is it Worse than HIV? Is it Mutating?

    IHV Co-Founder and Director, Robert Gallo, MD is interviewed on LBC, a radio station in the United Kingdom. Darren Adam had Professor Gallo on the line to discuss his research in the past and the work he's carrying out during the coronavirus crisis. "We have learned to live with HIV" Darren began, listing out how it has changed from a death sentence to a disease that humans can live a long life with. He wondered if this could be possibly the path we're taking with Covid-19.


    Wednesday, April 22, 2020

    Dr. Robert Gallo on India Today Discussing the Oral Polio Vaccine for COVID-19

    IndiaToday on Twitter - “Can oral polio vaccine help in fighting #Covid19? @DrRobertCGallo responds. #NewsToday with @sardesairajdeep


    Friday, April 17, 2020

    Dr. Robert Gallo Discusses Repurposing the Oral Polio Vaccine on CNN

    Dr. Robert Gallo discusses repurposing the oral polio vaccine, drug therapies and more on COVID-19 on CNN’s The Lead with Jake Tapper, April 17, 2020.


    Monday, April 13, 2020

    Can an Oral Polio Vaccine Stop COVID-19?

    Please see this just released Associated Press article, “Could old vaccines for other germs protect against COVID-19?” with Dr. Robert Gallo (Institute of Human Virology at the University of Maryland School of Medicine) and Dr. Konstantin Chumakov (U.S. Food and Drug Administration), both of the Global Virus Network (GVN).


    Wednesday, April 08, 2020

    Institute of Human Virology Co-founder on Coronavirus Recovery, Antibody Testing, Drug Testing, Bloomberg TV

    Dr. Robert Gallo, the Institute of Human Virology at the University of Maryland School of Medicine, Co-founder and director discusses the coronavirus. He speaks with Haidi Stroud-Watts and Shery Ahn on "Bloomberg Daybreak: Asia." (Source: Bloomberg)


    Tuesday, April 07, 2020

    A Deep Look Into The Coronavirus with Dr. Robert Gallo on WYPR (Baltimore’s local NPR station)

    (WNPR) Dr. Robert Gallo has been getting to know viruses-- their targets and their weaknesses--for decades, even before he co-discovered the virus that causes AIDS in the 1980s. At the University of Maryland’s Institute for Human Virology, which he heads, Gallo is looking at the coronavirus; he joins us to share his thoughts. Gallo is also co-founder and international scientific advisor at the Global Virus Network.


    Wednesday, April 01, 2020

    Dr. Robert Gallo Featured on MSNBC’s 11th Hour with Brian Williams

    Robert Gallo, MD, Co-Founder and Director of the Institute of Human Virology, discusses SARS-CoV-2/COVID-19, specifically, how he thinks the fight against the Coronavirus is going thus far.


    Friday, October 04, 2019

    Institute of Human Virology Hosts 21st Annual International Meeting of Top Scientists on Ending the HIV/AIDS Epidemic in America and the Intersection of Opioid Use Disorder

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine commenced IHV2019 held Thursday, October 3 through Friday, October 4 at the Four Seasons Hotel in Baltimore, Maryland. This year “Progress in HIV/AIDS: Challenges in 2020” opened with highlights about the recent plan for "Ending the HIV Epidemic by 2030” with expert opinions by ADM Brett Giroir, MD, Assistant Secretary for Health at the U.S. Department of Health and Human Services (HHS)


    Monday, August 26, 2019

    Dr. Robert Gallo Featured in Malcolm Gladwell's Podcast, "Revisionist History: The Obscure Virus Club"

    "Revisionist History" by Malcolm Gladwell: “The Obscure Virus Club,” featuring three prominent virologists, including Dr. Robert Gallo (as well as Dr. Ludwig Gross and Dr. Howard Temin).